Constantions G Missouris

Constantions G Missouris


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2020 in Postgraduate Medical Journal
Verified
Journal Article
Open access
PDF file
VBVadir Baktash
Vadir Baktash
THTom Hosack
Tom Hosack
NPNishil Patel
Nishil Patel
SSShital Shah
Shital Shah
PKPirabakaran Kandiah
Pirabakaran Kandiah
CMConstantions G Missouris
Constantions G Missouris
Purpose Older adults are more likely to be vitamin D deficient. The aim of the study was to determine whether these patients have worse outcomes with COVID-19. Methods We conducted a prospective cohort study between 1 March and 30 April 2020 to assess the importance of vitamin D deficiency in older patients with COVID-19. The cohort consisted of patients aged ≥65 years presenting with symptoms consistent with COVID-19 (n=105). All patients were tested for serum 25-hydroxyvitamin D (25(OH)D) levels during acute illness. Diagnosis of COVID-19 was confirmed via viral reverse transcriptase PCR swab or supporting radiological evidence. COVID-19-positive arm (n=70) was sub-divided into vitamin D-deficient (≤30 nmol/L) (n=39) and -replete groups (n=35). Subgroups were assessed for disease severity using biochemical, radiological and clinical markers. Primary outcome was in-hospital mortality. Secondary outcomes were laboratory features of cytokine storm, thoracic imaging changes and requirement of non-invasive ventilation (NIV). Results COVID-19-positive arm demonstrated lower median serum 25(OH)D level of 27 nmol/L (IQR=20–47 nmol/L) compared with COVID-19-negative arm, with median level of 52 nmol/L (IQR=31.5–71.5 nmol/L) (p value=0.0008). Among patients with vitamin D deficiency, there was higher peak D-dimer level (1914.00 μgFEU/L vs 1268.00 μgFEU/L) (p=0.034) and higher incidence of NIV support and high dependency unit admission (30.77% vs 9.68%) (p=0.042). No increased mortality was observed between groups. Conclusion Older adults with vitamin D deficiency and COVID-19 may demonstrate worse morbidity outcomes. Vitamin D status may be a useful prognosticator.

5 April 2023 in Aging Medicine
Verified
Journal Article
Open access
HWHo Lun Wong
Ho Lun Wong
CWClaire Weaver
Claire Weaver
LMLauren Marsh
Lauren Marsh
KMKhine Oo Mon
Khine Oo Mon
JDJohn M. Dapito
John M. Dapito
CMConstantions G Missouris
Constantions G Missouris
Introduction: Polypharmacy is a growing phenomenon associated with adverse effects in older adults. We assessed the potential confounding effects of cumulative anticholinergic burden (ACB) in patients who were hospitalized with falls.Methods: A noninterventional, prospective cohort study of unselected, acute admissions aged ≥ 65 years. Data were derived from electronic patient health records. Results were analyzed to determine the frequency of polypharmacy and degree of ACB and their relationship to falls risk. Primary outcomes were polypharmacy, defined as prescription of 5 or more regular oral medications, and ACB score.Key Results: Four hundred eleven (411) consecutive subjects were included, mean age 83.8 ± 8.0 years: 40.6% men. There were 38.4% patients who were admitted with falls. Incidence of polypharmacy was 80.8%, (88.0% and 76.3% among those admitted with and without fall, respectively). Incidence of ACB score of 0, 1, 2, ≥ 3 was 38.7%, 20.9%, 14.6%, and 25.8%, respectively. On multivariate analysis, age [odds ratio (OR) = 1.030, 95% CI:1.000 ~ 1.050, P = 0.049], ACB score (OR = 1.150, 95% CI:1.020 ~ 1.290, P = 0.025), polypharmacy (OR = 2.140, 95% CI:1.190 ~ 3.870, P = 0.012), but not Charlson Comorbidity Index (OR = 0.920, 95% CI:0.810 ~ 1.040, P = 0.172) were significantly associated with higher falls rate. Of patients admitted with falls, 29.8% had drug‐related orthostatic hypotension, 24.7% had drug‐related bradycardia, 37.3% were prescribed centrally acting drugs, and 12.0% were taking inappropriate hypoglycemic agents.Conclusion: Polypharmacy results in cumulative ACB and both are significantly associated with falls risk in older adults. The presence of polypharmacy and each unit rise in ACB score have a stronger effect of increasing falls risk compared to age and comorbidities.

1 October 2020 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
JKJason Kho
Jason Kho
AIAdam Ioannou
Adam Ioannou
KAKoenraad Van Den Abbeele
Koenraad Van Den Abbeele
AMAmit K.J. Mandal
Amit K.J. Mandal
CMConstantions G Missouris
Constantions G Missouris

1 July 2020 in Clinical Toxicology
Verified
Journal Article
Closed access
JKJason Kho
Jason Kho
AIAdam Ioannou
Adam Ioannou
AMAmit K. J. Mandal
Amit K. J. Mandal
ACAndrew Cox
Andrew Cox
ANAshraf Nasim
Ashraf Nasim
CMConstantions G Missouris
Constantions G Missouris
Background: The neurocognitive benefits of donepezil are well recognised, but the potential side effects on cardiac conduction remain unclear. Objective: To investigate whether long-term donepezil therapy is associated with electrocardiographic (ECG) changes and in particular to assess its effects on the QT interval. Methods: We conducted a single centre retrospective analysis of patients admitted to our trust on donepezil therapy over a 12-month period. An admission resting 12-lead ECG was obtained and compared to their ECG prior to commencement of donepezil therapy to assess for any significant difference in ECG parameters. Results: We identified 59 patients suitable for analysis. PR (177.0 ± 29.0 ms vs. 186.1 ± 34.2 ms, p = 0.04), QRS (101.7 ± 20.3 ms vs. 104.7 ± 22.3 ms, p = 0.04) and QT (393.3 ± 35.6 ms vs. 411.9 ± 44.6 ms, p = 0.002) interval prolongation were all associated with donepezil use. The increase in QT intervals remained significant on correction for heart rate; resulting in 8 (13.6%) patients developing high arrhythmogenic risk based on assessment using QT nomogram plots. Concomitant use of tricyclic antidepressants was associated with significant QT prolongation (QTcB: rpb = 0.344, p = 0.008, QTcFred: rpb = 0.382, p = 0.003, QTcFram: rpb = 0.379, p = 0.003, QTcH: rpb = 0.352, p = 0.006), while the use of rate-limiting calcium channel blockers was associated with significant PR prolongation (rpb = 0.314, p = 0.030), and beta-blockers with a reduction in heart rate (rpb = 0.256, p = 0.050). Conclusion: Our results clearly demonstrate that long-term use of donepezil is associated with prolongation of the QT interval. We suggest ECG evaluation should take place before and after donepezil initiation, and clinicians should be even more vigilant in those prescribed tricyclic antidepressants.

1 January 2021 in Respiratory Medicine
Verified
Journal Article
Closed access
AMAmit K.J. Mandal
Amit K.J. Mandal
JKJason Kho
Jason Kho
AIAdam Ioannou
Adam Ioannou
KAKoenraad Van Den Abbeele
Koenraad Van Den Abbeele
CMConstantions G Missouris
Constantions G Missouris

30 October 2018 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KCKatrina Lennon Collins
Katrina Lennon Collins
FZFady Zakharious
Fady Zakharious
AMAmit K. J. Mandal
Amit K. J. Mandal
CMConstantions G Missouris
Constantions G Missouris
Pericardial cysts are uncommon benign lesions of the middle mediastinum, making up less than 6% of all mediastinal masses. They are often detected as incidental findings on chest imaging and some can resolve spontaneously. Rarely, however, they may cause symptoms of chest pain, right ventricular outflow obstruction, and persistent cough. Furthermore, they may affect cardiac tamponade after acute rupture or cyst haemorrhage resulting in sudden death. We report the case of a 102-year-old woman presenting with urosepsis, in whom routine chest radiography was initially suspicious of advanced bronchial carcinoma. Further imaging supported a diagnosis of one of the largest pericardial cysts described in the literature located in the right parahilar space. The patient was appropriately managed conservatively.